Studies found many prenatal supplements contain too much folic acid and often have higher nutrient content than labeled, while vitamin D supplementation improves babies' growth. A healthier diet before pregnancy may lower the risk of preeclampsia, and obesity severity affects weight gain and baby size during pregnancy
A study of adults and youth with type 2 diabetes found that improvements in insulin release wane after treatment stops, highlighting the need for continued treatment. In contrast, youth experience more aggressive disease progression during and after treatment.
A new study suggests that policies targeting taxes, warning labels, and food subsidies could reduce cancer cases by up to 77,000. Implementing these policies could save an estimated $1.4 billion in direct medical costs and prevent over 35,500 obesity-related cancer cases.
Research found that participants who shifted their sleep/wake timings could bring forward their bedtime and wake-up time by two hours, leading to improvements in depression, stress, and daytime sleepiness. Participants also reported better mental well-being and increased cognitive performance during the morning.
A new study found that people who get less than 7 hours of sleep per night tend to consume fewer essential vitamins and minerals. The research also revealed a greater association between poor sleep and lower nutrient intake in women.
Researchers found that sun-exposed oyster mushrooms can increase vitamin D levels and improve immunological responses in TB patients. The study used bread containing the mushrooms, which showed significant improvements in patients' TB severity scores and reduced vitamin D deficiency.
A study estimates that a national SSB tax could prevent around 17,000 new obesity-associated cancer cases and save $2.4 billion in lifetime medical costs. Health warnings on SSBs can also reduce purchases and consumption, with potential to reduce average body mass index by about 0.6 kg/m2 over 5 years.
A large international clinical trial found that dulaglutide reduced cardiovascular events by 12% and kidney disease by 15% in people with Type 2 diabetes. The study, REWIND, followed over 9,900 participants for five years.
A randomized controlled trial found that telemedicine cognitive behavioral therapy for insomnia was equally effective to in-person delivery in improving sleep outcomes. Participants reported no differences in therapist alliance or satisfaction with treatment between the two groups.
Researchers found that an immunotherapy treatment, teplizumab, effectively delayed the progression to clinical type 1 diabetes in high-risk individuals. Participants who received teplizumab took longer to develop clinical disease, with a median time of 48 months compared to just over 24 months for those in the control group.
A randomized clinical trial found that patients taking IDegLira achieved and maintained lower blood glucose levels for longer periods compared to those taking insulin only. The study showed improved outcomes without the need for additional therapy, reducing side effects often associated with insulin-only treatment.
Two new trials show oral semaglutide is more effective than subcutaneous liraglutide in treating type 2 diabetes, with the latest trial showing it's also safe for patients with moderate renal impairment. Another trial found that insulin degludec plus liraglutide is a durable therapy option for type 2 diabetes.